In a week marked by significant developments in global health and biotechnology, a Kenyan court has suspended a US plan to establish a quarantine facility for Americans exposed to Ebola, while Allogene's CEO has stepped down. Meanwhile, the XPRIZE Healthspan longevity competition is gaining momentum, with its founder highlighting the most promising research and debunking "scammy" treatments.
Story mode
Gethin trains to be Dr Oscar's guide runner
A Kenyan court suspends a US plan for an Ebola quarantine facility, Allogene's CEO steps down, and the XPRIZE Healthspan longevity competition gains momentum.
- Read
- 2 min
- Sources
- 5 sources
- Domains
- 2
- Sections
- 6
In a week marked by significant developments in global health and biotechnology, a Kenyan court has suspended a US plan to establish a quarantine facility for Americans exposed to Ebola, while Allogene's CEO has stepped...
- Story state
- Deep multi-angle story
- Evidence
- What Happened
- Coverage
- 6 reporting sections
- Next focus
- What Comes Next